Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
After two years of dedicated and persistent advocacy by ADI, dementia will, for the first time, be formally recognised within the new UN Political Declaration on noncommunicable diseases (NCDs) and mental health, as a leading NCD.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
ADI is pleased to invite MoCA Cognition, a Canadian company led by Dr. Nasreddine, focused on research and innovation of cognitive assessments grounded in the Montreal Cognitive Assessment (MoCA), to share their recent case study of a newly developed tool: MoCA-Xpresso. The tool highlights encouraging data that demonstrates how…
In February, ADI CEO Paola Barbarino and Head of Membership Laura Aubert visited Morocco for a series of high-level stakeholder and member meetings aimed at expediting progress towards addressing dementia in the country.
Argentina has officially launched its first National Dementia Plan, a major milestone for the country and the Americas region, following years of persistent advocacy.
ADI hosts African regional member meeting The event brought together 17 ADI members and developing members across the African continent to discuss shared challenges, exchange ideas and foster solidarity and collaboration across the region.
As we approach the end of the calendar year, ADI CEO Paola Barbarino shares her end-of-year message with our members, friends and colleagues, reflecting on our work in 2025 and offering a preview of what 2026 will bring.
9 December, ADI CEO Paola Barbarino joined the 19th Rencontre France Alzheimer, hosted by France Alzheimer in Paris. This event convened representatives from across the country, as well as and Francophone countries, to discuss the latest developments in dementia treatment, diagnostics, care and support.
On 10 December, ADI held its 2nd End of Year forecast event, focusing on the important topic of diagnosis under the theme of ‘The Diagnostics Revolution; Are We Ready’. Watch the recording and read ADI's highlights.
ADI welcomes the approval of Peru’s National Plan for the Prevention and Treatment of Alzheimer’s Disease and Other Dementias 2026–2028, officially validated by the Ministry of Health through a newly published ministerial resolution. This landmark decision places dementia firmly on Peru’s national health agenda and opens the door to implementation after years of dedicated advocacy from civil society, academia, and key partners.